Presentation is loading. Please wait.

Presentation is loading. Please wait.

Associations between the ‘% of patients that ever used a bDMARD’ and the ‘composite score clinical criteria’, ‘composite score access to medication’ and.

Published byἨώς Αναστασιάδης Modified over 5 years ago

Similar presentations

Presentation on theme: "Associations between the ‘% of patients that ever used a bDMARD’ and the ‘composite score clinical criteria’, ‘composite score access to medication’ and."— Presentation transcript:

1 Associations between the ‘% of patients that ever used a bDMARD’ and the ‘composite score clinical criteria’, ‘composite score access to medication’ and clinical outcomes. bDMARD, biological disease modifying antirheumatic drugs; BR, Brazil; ES, Spain; FR, France; GDP, gross domestic product; IE, Ireland; IN, India; JP, Japan; MX, Mexico; NL, Netherlands; PT, Portugal; SA, South Africa. Associations between the ‘% of patients that ever used a bDMARD’ and the ‘composite score clinical criteria’, ‘composite score access to medication’ and clinical outcomes. bDMARD, biological disease modifying antirheumatic drugs; BR, Brazil; ES, Spain; FR, France; GDP, gross domestic product; IE, Ireland; IN, India; JP, Japan; MX, Mexico; NL, Netherlands; PT, Portugal; SA, South Africa. Sytske Anne Bergstra et al. Ann Rheum Dis 2018;77: ©2018 by BMJ Publishing Group Ltd and European League Against Rheumatism

Download ppt "Associations between the ‘% of patients that ever used a bDMARD’ and the ‘composite score clinical criteria’, ‘composite score access to medication’ and."

Similar presentations

Total Consumption Rate of Industrial Minerals & Ore and Construction Materials in the year 2000 (tons of Domestic Material Consumption/capita/year) Figure.

Total Consumption Rate of Industrial Minerals & Ore and Construction Materials in the year 2000 (tons of Domestic Material Consumption/capita/year) Figure.
The United States The Economy. What is GDP ? Gross Domestic Product (GDP): The total market (or dollar) value of all final goods and services produced.

The United States The Economy. What is GDP ? Gross Domestic Product (GDP): The total market (or dollar) value of all final goods and services produced.
GREAT CANADIAN FLAG DEBATE. STEP 1: MATCH THE FLAG TO THE COUNTRY Australia, Belgium, Brazil, Britain, China, Denmark, Egypt, Finland, Germany, Iceland,

GREAT CANADIAN FLAG DEBATE. STEP 1: MATCH THE FLAG TO THE COUNTRY Australia, Belgium, Brazil, Britain, China, Denmark, Egypt, Finland, Germany, Iceland,
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71:700-706 doi:10.1136/annrheumdis-2011-200358.

Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71: doi: /annrheumdis
Algorithm based on the 2016 European League Against Rheumatism (EULAR) recommendations on rheumatoid arthritis (RA) management. Algorithm based on the.

Algorithm based on the 2016 European League Against Rheumatism (EULAR) recommendations on rheumatoid arthritis (RA) management. Algorithm based on the.
الادارة الصحية: المفهوم والأهمية والخصوصية

الادارة الصحية: المفهوم والأهمية والخصوصية
Figure 3 Simplified EULAR and GRAPPA

Figure 3 Simplified EULAR and GRAPPA
Figure 2 Simplified EULAR and GRAPPA

Figure 2 Simplified EULAR and GRAPPA
For 24 countries with more than 20 citations, this figure compares contributions to ESMO and the UK cancer CPGs. Solid line of identity indicates equal.

For 24 countries with more than 20 citations, this figure compares contributions to ESMO and the UK cancer CPGs. Solid line of identity indicates equal.
Mean change from baseline in disease and disability outcomes at 6 months for abatacept initiators by anti-CCP status. Mean change from baseline in disease.

Mean change from baseline in disease and disability outcomes at 6 months for abatacept initiators by anti-CCP status. Mean change from baseline in disease.
(A) EULAR response based on DAS28 (ESR, otherwise CRP) and (B) Boolean remission, at 6 months in patients treated with abatacept as a first-line biologic.

(A) EULAR response based on DAS28 (ESR, otherwise CRP) and (B) Boolean remission, at 6 months in patients treated with abatacept as a first-line biologic.
(A) Lequesne index and quadriceps strength of patients with knee OA

(A) Lequesne index and quadriceps strength of patients with knee OA
Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Management of hyperuricaemia in.

Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Management of hyperuricaemia in.
Worldwide distribution of clinical cases of hepatitis E virus (HEV) infection. Worldwide distribution of clinical cases of hepatitis E virus (HEV) infection.

Worldwide distribution of clinical cases of hepatitis E virus (HEV) infection. Worldwide distribution of clinical cases of hepatitis E virus (HEV) infection.
Percentage of patients achieving EULAR response

Percentage of patients achieving EULAR response
Efficacy end points: the percentage of patients achieving an improvement in American College of Rheumatology (ACR) of (A) 20% (ACR20), (B) 50% (ACR50)

Efficacy end points: the percentage of patients achieving an improvement in American College of Rheumatology (ACR) of (A) 20% (ACR20), (B) 50% (ACR50)
Mean change from baseline in disease and disability outcomes at 6 months for TNFi initiators by anti-CCP status. Mean change from baseline in disease and.

Mean change from baseline in disease and disability outcomes at 6 months for TNFi initiators by anti-CCP status. Mean change from baseline in disease and.
HAQ-DI change from baseline and proportion of patients achieving MCID after 24 weeks in patients treated with PBO, IXEQ4W or IXEQ2W alone or in combination.

HAQ-DI change from baseline and proportion of patients achieving MCID after 24 weeks in patients treated with PBO, IXEQ4W or IXEQ2W alone or in combination.
Groundwater bodies - overview

Groundwater bodies - overview
Different treatment strategies in rheumatoid arthritis in relation to radiographic progression (A) number of swollen joints (B) and fatigue severity over.

Different treatment strategies in rheumatoid arthritis in relation to radiographic progression (A) number of swollen joints (B) and fatigue severity over.

Similar presentations

Ads by Google